Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

Precision Telemed vs Teleios Health

Two GLP-1 deals, scored on the same six factors. Precision Telemed lands a Value Score of 89, Teleios Health a 72. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

Precision Telemed

#10 · Grade A · Great Deal

Est. first month

$149/mo

Save ~89% vs brand-name
Get this deal Full Precision Telemed review →
VS

Teleios Health

#208 · Grade C · Watch List

Est. first month

From $99/mo (starting dose, compounded)

Save ~93% vs brand-name
Get this deal Full Teleios Health review →

The verdict

Better value: Precision Telemed

Precision Telemed takes it on Value Score, 89 to 72 an est. $149/mo first month, with no teaser step-up baked in. Teleios Health isn't out of it: Shoppers who want physician-prescribed compounded GLP-1 from a $99/mo floor.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealPrecision TelemedTeleios Health
Value Score89 (A)72 (C)
Est. first month$149/moFrom $99/mo (starting dose, compounded)
Save vs brand-name~89%~93%
Semaglutide$149/moFrom $99/mo (starting dose, compounded)
Tirzepatide$199/moFrom $139/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 statesCoverage not published

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

88
Lowest Real Price
90
Precision Telemed: 88. Teleios Health: 90.
86
No Teaser-Rate Bait
64
Precision Telemed: 86. Teleios Health: 64.
98
Nationwide Availability
45
Precision Telemed: 98. Teleios Health: 45.
92
Both Molecules
92
Precision Telemed: 92. Teleios Health: 92.
84
Easy Cancellation
58
Precision Telemed: 84. Teleios Health: 58.
82
Reputation
37
Precision Telemed: 82. Teleios Health: 37.

Precision Telemed

A LegitScript-certified, all-50-state program with an honest $149 / $199 flat price on both molecules.

Why it's a deal

  • LegitScript-certified and available in all 50 states
  • Flat $149 semaglutide / $199 tirzepatide — no step-up
  • Both molecules priced up front

The fine print

  • Not the rock-bottom sticker — sub-$100 sema tiers exist
  • No brand-name or oral option

Teleios Health

Teleios Health is a physician-led, cash-pay GLP-1 weight-loss platform marketing compounded semaglutide from $99/mo and compounded tirzepatide from $139/mo, delivered direct to your door through a fully…

Why it's a deal

  • Compounded semaglutide from $99/mo — among the lowest floor prices in cash-pay telehealth
  • Compounded tirzepatide from a competitive $139/mo floor
  • Markets physician (MD/DO) prescribing rather than an NP-only model
  • Clean meta-tag and SEO implementation

The fine print

  • Single-page app: state availability, pharmacy partner, dose pricing, lab requirements, and refund policy aren't visible and couldn't be verified
  • No named medical director, physician, or corporate entity disclosed
  • Year founded unknown — a newer floor-price entrant warranting extra scrutiny
  • No LegitScript, NABP, or SOC 2 trust signal found
  • Heavy paid-acquisition ad-tech stack — pair with diligence on the clinical layer
Get the Precision Telemed deal Get the Teleios Health deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores Precision Telemed is ranked on the Precision Telemed alternatives board, and the same list for the other side is on alternatives to Teleios Health.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.